MIOT
BOLD

Massachusetts Institute of Technology’s Audentes Therapeutics, Inc BOLD Stock Holding History

Massachusetts Institute of Technology’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-27,931
Closed -$1.09M – 7
2019
Q1 		$1.09M Buy
+27,931
New +$801K 0.93% 3

Other funds holding BOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Institute of Technology's BOLD Position: Q2 2019 in Review

Massachusetts Institute of Technology sold out of Audentes Therapeutics, Inc (BOLD) in Q2 2019, closing a stake of 27,931 shares — an estimated $1.09M sold.

Massachusetts Institute of Technology first reported a position in BOLD in Q1 2019 and held it in 1 quarter. The position peaked at $1.09M in Q1 2019. 147 funds tracked by Wall St. Rank hold BOLD as of Q2 2019.

  • Massachusetts Institute of Technology reported no remaining Audentes Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
  • Massachusetts Institute of Technology sold 27,931 Audentes Therapeutics, Inc shares in Q2 2019, an estimated $1.09M.
  • Massachusetts Institute of Technology first reported a position in Audentes Therapeutics, Inc in Q1 2019 and held it in 1 quarter.
  • Massachusetts Institute of Technology's Audentes Therapeutics, Inc position peaked at $1.09M in Q1 2019.
  • 147 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q2 2019.

Based on Massachusetts Institute of Technology's 13F filing for Q2 2019, filed 9 Aug 2019.